| abstract |
The present invention relates to adenosine A3 receptor ligands of general formula (I) within them favorable to antagonists, their salts, solvates, N-oxides and isomers, to pharmaceutical compositions containing the formula compounds general (I), its salts, solvates, N-oxides and isomers, to the use of the compounds of general formula (I), its salts, solvates, N-oxides and isomers, to the preparation of the compounds of general formula (I ), its salts, solvates, N-oxides and isomers, as well as the new intermediaries of general formula (II), (VI), (XI), (XII) and (XV) and their preparation. |